Safety and efficacy of drug-eluting stents versus heparin-bonded stents in treatment of femoropopliteal peripheral artery disease: study protocol for a multicentre, prospective randomised controlled trial in China (ELITE trial)
ELITE trial was registered on 27 September 2023 in the Chinese Clinical Trials Registry (ChiCTR2300076236).
Authors
- Jiarong Wang (ORCID: https://orcid.org/0000-0002-0377-8083)
- Chengxin Weng
- Yuhan Qi (ORCID: https://orcid.org/0000-0003-4081-9064)
- Bin Huang (ORCID: https://orcid.org/0000-0003-4767-0629)
- Tiehao Wang (ORCID: https://orcid.org/0000-0003-1607-3995)
- Jinting Ge (ORCID: https://orcid.org/0000-0003-0952-5850)
- Jichun Zhao (ORCID: https://orcid.org/0000-0001-8185-1373)
- Ding Yuan (ORCID: https://orcid.org/0000-0001-8066-8155)
- Huawei Zhang (ORCID: https://orcid.org/0009-0002-0265-1176)
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
Publication Details
- Journal
- BMJ Open
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1136/bmjopen-2023-080560
- Citations
- 1
- Primary Topic
- Peripheral Artery Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- National Natural Science Foundation of China
- Sichuan Province Science and Technology Support Program
- West China Hospital, Sichuan University